News & updates related to Covid-19
SARS-CoV-2 IgG Serology Testing
This assay can potentially be used to assess vaccine response and to detect previous infection.
CLLANZ Newsletter September 2021 – Learn the latest international developments in CLL treatments
CLLANZ Newsletter September 2021
‘I am screwed if it comes back’ Experts concerned by Covid’s hidden impact on blood cancer treatments
Around 21,000 Kiwis are living with blood cancer. Symptoms can be difficult to recognisegnise
Who will be eligible for a third Covid jab in the UK?
Half a million people will be offered another vaccine shot, with a decision on autumn boosters yet…
Responses to COVID-19 Vaccines Vary in Patients With Hematologic Malignancies
Research has suggested that patients with hematologic malignancies may not mount an effective…
Pharmac commits to being more transparent
On 28 July for the first time Pharmac released its ‘Options for investment list’.
As a Cancer Patient, Will I Need an Extra Dose of a COVID-19 Vaccine?
This is the sixth in a multipart series exploring important questions about COVID-19 and its unique…
Covid-19 Vaccines May Not Produce Sufficient Antibody Response in Transplant Recipients
When clinical trials were conducted to determine the immunogenicity — the ability to elicit an…
CLL Advocates Newsletter Issue 12
Covid-19 and CLL prevention and treatment - an update.
R. Gregory BD, discusses outcomes for patients with chronic lymphocytic leukemia and COVID-19.
R. Gregory Bociek, MD, an associate professor of internal medicine, Division of Oncology and…
CLL Advocates Newsletter Issue 8
Welcome to issue 8 of the CLL Advocates newsletter.
Case Study: COVID-19 and the Coexistence of CLL
Many symptoms of SARS-CoV-2 (COVID-19) can be concealed due the coexistence of malignant…
CLL and COVID-19: What Should Patients Know About Vaccines?
With the flu season approaching and whispers of a vaccine for COVID-19 in the works, CLL patients…
COVID-19 Severity in CLL Correlates With 3 Disease Characteristics
The severity of coronavirus disease 2019 increases with age in patients with chronic lymphocytic…
CLL Experts Favor Social Distancing, but Vary on Treatment Continuation Amid Pandemic
Experts surveyed regarding how best to treat patients with chronic lymphocytic leukemia (CLL) amid…
Age, Recent Treatment, Appear to Influence Severity of COVID-19 in Patients With CLL
Older patients with chronic lymphocytic leukemia (CLL) appear to be more likely to have severe…
Changes in Management of CLL Due to COVID-19 Noted in Italy
The management of CLL, including delays in work-up and treatment, and modifications to clinical…
Coronavirus: Separating Fact From Fiction for CLL Patients
“We're learning every day, and we're modifying and adjusting based on what we learn,” says Dr.…
COVID-19’s Impact on How Patients with CLL, Myeloma Have Received Treatment
In the first installment of CURE®’s inaugural webinar series, “Hear from the Experts: COVID-19 &…
How COVID-19 Has Impacted Clinical Trials for Chronic Lymphocytic Leukemia
The COVID-19 Pandemic has changed immediate treatment for patients with chronic lymphocytic…
CLLANZ calls for home-based treatment for CLL patients during COVID pandemic
We’ve been concerned about the current COVID-related risks to CLL patients who may be delaying…
How it feels to be in intensive care with COVID-19 – a survivor with CLL
"I had never felt so alone in all my life," writes coronavirus survivor Robin Bowler in his…
Patient With CLL May Have Had Longer COVID-19 Incubation Period
A case report out of China suggested that clinical and biochemical data of COVID-19 might have been…